Vaha-Koskela M - Search Results

1

Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System.

Cerullo V, Capasso C, Vaha-Koskela M, Hemminki O, Hemminki A. Cerullo V, et al. Curr Cancer Drug Targets. 2018;18(2):124-138. doi: 10.2174/1568009617666170502152352. Curr Cancer Drug Targets. 2018. PMID: 28464762 Review.

2

Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.

Vähä-Koskela MJ, Kallio JP, Jansson LC, Heikkilä JE, Zakhartchenko VA, Kallajoki MA, Kähäri VM, Hinkkanen AE. Vähä-Koskela MJ, et al. Cancer Res. 2006 Jul 15;66(14):7185-94. doi: 10.1158/0008-5472.CAN-05-2214. Cancer Res. 2006. PMID: 16849565

3

Oncolytic viruses in cancer therapy.

Vähä-Koskela MJ, Heikkilä JE, Hinkkanen AE. Vähä-Koskela MJ, et al. Cancer Lett. 2007 Sep 8;254(2):178-216. doi: 10.1016/j.canlet.2007.02.002. Epub 2007 Mar 23. Cancer Lett. 2007. PMID: 17383089 Free PMC article. Review.

4

Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans.

Cerullo V, Koski A, Vähä-Koskela M, Hemminki A. Cerullo V, et al. Adv Cancer Res. 2012;115:265-318. doi: 10.1016/B978-0-12-398342-8.00008-2. Adv Cancer Res. 2012. PMID: 23021247 Review.

5

Oncolytic adenoviruses: A potent form of tumor immunovirotherapy.

Cerullo V, Vähä-Koskela M, Hemminki A. Cerullo V, et al. Oncoimmunology. 2012 Sep 1;1(6):979-981. doi: 10.4161/onci.20172. Oncoimmunology. 2012. PMID: 23162778 Free PMC article.

6

Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma.

Vähä-Koskela MJ, Le Boeuf F, Lemay C, De Silva N, Diallo JS, Cox J, Becker M, Choi Y, Ananth A, Sellers C, Breton S, Roy D, Falls T, Brun J, Hemminki A, Hinkkanen A, Bell JC. Vähä-Koskela MJ, et al. J Virol. 2013 Feb;87(4):2363-6. doi: 10.1128/JVI.01609-12. Epub 2012 Dec 5. J Virol. 2013. PMID: 23221568 Free PMC article.

7

MicroRNA-mediated suppression of oncolytic adenovirus replication in human liver.

Ylösmäki E, Lavilla-Alonso S, Jäämaa S, Vähä-Koskela M, af Hällström T, Hemminki A, Arola J, Mäkisalo H, Saksela K. Ylösmäki E, et al. PLoS One. 2013;8(1):e54506. doi: 10.1371/journal.pone.0054506. Epub 2013 Jan 22. PLoS One. 2013. PMID: 23349911 Free PMC article.

8

In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders.

Hemminki O, Immonen R, Närväinen J, Kipar A, Paasonen J, Jokivarsi KT, Yli-Ollila H, Soininen P, Partanen K, Joensuu T, Parvianen S, Pesonen SK, Koski A, Vähä-Koskela M, Cerullo V, Pesonen S, Gröhn OH, Hemminki A. Hemminki O, et al. Int J Cancer. 2014 Jun 15;134(12):2878-90. doi: 10.1002/ijc.28615. Epub 2013 Dec 6. Int J Cancer. 2014. PMID: 24248808 Free article.

9

CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging.

Parviainen S, Ahonen M, Diaconu I, Hirvinen M, Karttunen Å, Vähä-Koskela M, Hemminki A, Cerullo V. Parviainen S, et al. Gene Ther. 2014 Feb;21(2):195-204. doi: 10.1038/gt.2013.73. Epub 2013 Dec 5. Gene Ther. 2014. PMID: 24305418

10

Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma.

Siurala M, Bramante S, Vassilev L, Hirvinen M, Parviainen S, Tähtinen S, Guse K, Cerullo V, Kanerva A, Kipar A, Vähä-Koskela M, Hemminki A. Siurala M, et al. Int J Cancer. 2015 Feb 15;136(4):945-54. doi: 10.1002/ijc.29048. Epub 2014 Jul 3. Int J Cancer. 2015. PMID: 24975392 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page